Every two minutes a woman dies in pregnancy or childbirth around the globe. During its operation, VSI worked to change this by connecting women with life-saving medicines and services. This document provides an overview of VSI’s approach to access as well as key accomplishments improving product availability in developing countries.
A pocket reference for clinicians, this Misoprostol Regimens Pocket Guide from Rwanda details the dosage and route recommendations for the administraiton of misoprostol use in obstetrics and gynecology.
A guide to assist program planners on developing information, education and communication (IEC) campaigns as part of a misoprostol program. The focus of the content and messaging is on misoprostol for the prevention and treatment of postpartum hemorrhage (PPH) in Africa.
Information, education and communication (IEC) campaign sample from a postabortion care (PAC) operations research project in Rwanda written using the local Kinyarwanda language.
This brief summarizes the final results from a collaborative postabortion care (PAC) operations research led by the Zimbabwe Ministry of Health and Child Care and VSI. The results demonstrate that misoprostol, a safe and effective treatment option for incomplete abortion and miscarriage, brings PAC services closer to women in need at all levels of the health system.
The Zimbabwe Ministry of Health and Child Care and VSI conducted an operations research to address maternal deaths associated with postpartum hemorrhage (PPH). This brief provides strong evidence that introducing misoprostol as an alternative uterotonic when oxytocin is not available can effectively expand uterotonic coverage to women delivering in health facilities.
Information, education and communication (IEC) campaign sample from a postpartum hemorrhage (PPH) operations research project in Rwanda using the local Kinyarwanda language.
Osur and colleagues’ article on the evaluation findings of implementing misoprostol for post- abortion care (PAC) in Kenya and Uganda provides valuable lessons learned and best practices. Venture Strategies Innovations (VSI), a global health non-profit organization, is currently introducing misoprostol for PAC with the Ministries of Health (MOH) in Rwanda and Zimbabwe, and based on our ongoing implementation experiences, we would suggest a few additional lessons.
The Angola Ministry of Health, in collaboration with VSI, conducted a demonstration project aimed at addressing maternal deaths due to complications from unsafe abortion. This research brief demonstrates that misoprostol is a safe, effective and feasible treatment method for incomplete abortion at all levels of the health system, including those facilities that do not have the capacity for manual vacuum aspiration or other surgical interventions.
